Abstract

The specificity of the antibody response against Zika virus (ZIKV) is not well-characterized. This is due, in part, to the antigenic similarity between ZIKV and closely related dengue virus (DENV) serotypes. Since these and other similar viruses co-circulate, are spread by the same mosquito species, and can cause similar acute clinical syndromes, it is difficult to disentangle ZIKV-specific antibody responses from responses to closely-related arboviruses in humans. Here we use high-density peptide microarrays to profile anti-ZIKV antibody reactivity in pregnant and non-pregnant macaque monkeys with known exposure histories and compare these results to reactivity following DENV infection. We also compare cross-reactive binding of ZIKV-immune sera to the full proteomes of 28 arboviruses. We independently confirm a purported ZIKV-specific IgG antibody response targeting ZIKV nonstructural protein 2B (NS2B) that was recently reported in ZIKV-infected people and we show that antibody reactivity in pregnant animals can be detected as late as 127 days post-infection (dpi). However, we also show that these responses wane over time, sometimes rapidly, and in one case the response was elicited following DENV infection in a previously ZIKV-exposed animal. These results suggest epidemiologic studies assessing seroprevalence of ZIKV immunity using linear epitope-based strategies will remain challenging to interpret due to susceptibility to false positive results. However, the method used here demonstrates the potential for rapid profiling of proteome-wide antibody responses to a myriad of neglected diseases simultaneously and may be especially useful for distinguishing antibody reactivity among closely related pathogens.

Highlights

  • Serologic assays designed to detect Zika virus (ZIKV) infection suffer from cross-reactivity with antibodies to closely related dengue virus (DENV), due to the high level of amino acid sequence identity and structural similarity [1,2,3,4] between the two viruses

  • We show that while ZIKV-specific antibody binding can be detected, these responses are generally weak and ephemeral, and false positives may arise through DENV infection

  • We synthesized linear 16-mer peptides, overlapping by 12 amino acids, representing the SIVmac239 envelope protein and analyzed serum from two Mauritian cynomolgus macaques for simian immunodeficiency virus (SIV)-specific IgG reactivity before and approximately 125 days after SIVmac239 infection (Table 1). (We have previously plotted data procured from peptide array assays of these samples [38] while investigating the antibody response to SIV in the context of simian pegivirus infection; here we show the same data using the updated, improved data processing pipeline described above.) Post-infection samples showed fluorescence intensity as high as 1,000 times the intensity in pre-infection samples (S1 Fig)

Read more

Summary

Introduction

Serologic assays designed to detect Zika virus (ZIKV) infection suffer from cross-reactivity with antibodies to closely related dengue virus (DENV), due to the high level of amino acid sequence identity (average ~55%) and structural similarity [1,2,3,4] between the two viruses. Serologic assays have been developed to detect past ZIKV infection, reporting sensitivity varying from 37% to 97% and specificity varying from 20% to 90% [5,6,7,8]. A recent publication by Mishra et al employed a high-density peptide microarray to identify antibodies to linear ZIKV epitopes lacking crossreactivity with other flaviviruses [13]. This group identified an IgG immunoreactive peptide sequence in the ZIKV nonstructural protein 2B (NS2B) which induced little antibody binding in serum from ZIKV-naive people and was bound in early convalescence in most cases of symptomatic ZIKV infection [13]. This group did note seropositivity in a ZIKV-naive, DENVimmune individual and in one individual with no known flavivirus infection history

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call